Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Automated Remifentanil vs Sufentanil for Postoperative Hyperalgesia
NCT00772616Phase 4Completed
- Sponsor
- Hôpital Foch
- Start
- Sep 2008
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in Anesthesia (2 arms), sponsored by Hôpital Foch. Primary endpoint: Dose of morphine administered during the postoperative period at 48 hours. Started Sep 2008; status: completed.
02
Drugs
remifentanil
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT00772616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772616.